Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19222369

Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome

Author
NAKAMURA, R1 ; RODRIGUEZ, R1 ; KOGUT, N4 ; PULLARKAT, V1 ; KIRSCHBAUM, M1 ; FORMAN, S. J1 ; O'DONNELL, M. R1 ; PALMER, J2 ; STEIN, A1 ; NAING, A1 ; TSAI, N2 ; CHANG, K3 ; SLOVAK, M. L3 ; BHATIA, R1 ; SPIELBERGER, R4
[1] Division of Hematology/Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, United States
[2] Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States
[3] Division of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States
[4] The City of Hope-Southern California Kaiser Permanente Bone Marrow Transplant Program, Duarte, CA, United States
Source

Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 9, pp 843-850, 8 p ; ref : 30 ref

CODEN
BMTRE9
ISSN
0268-3369
Scientific domain
Medical oncology; Graft, transplantation; Hematology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
: myelodysplastic syndromes (MDS) acute myelogenous leukemia arising from MDS allogeneic hematopoietic stem cell transplantation fludarabine and melphalan reduced intensity conditioning
Keyword (fr)
Anticancéreux Cellule hématopoïétique Cellule souche Conditionnement atténué Fludarabine Homogreffe Hématologie Melphalan Myélodysplasique syndrome Analogue nucléotide Leucémie aiguë myéloblastique Agent alkylant Antimétabolite Fluor Composé organique Greffe Hémopathie maligne Moutarde à l'azote Purine nucléotide
Keyword (en)
Antineoplastic agent Hematopoietic cell Stem cell Non myeloablative treatment Fludarabine Homograft Hematology Melphalan Myelodysplastic syndrome Acute myelogenous leukemia Alkylating agent Antimetabolic Fluorine Organic compounds Graft Malignant hemopathy Nitrogen mustard Purine nucleotide
Keyword (es)
Anticanceroso Célula hematopoyética Célula primitiva Tratamiento no mieloablativo Fludarabina Homoinjerto Hematología Melfalán Mielodisplastico síndrome Leucemia aguda mieloblástica Agente alquilante Antimetabólito Fluor Compuesto orgánico Injerto Hemopatía maligna Mostaza al nitrógeno Purina nucleótido
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction

Discipline
Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Blood diseases
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
19222369

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web